ARCHIVES

FDA To Issue “Complete Response” Letters To Drug Sponsors.

This article is from The Cancer Letter archive.

Vol. 34 No. 27 | July 11, 2008

Download PDF Visit The Full Archive

Related Articles

Preoperative Drug Combo Benefits HER-2 Breast Cancer

April 29, 2005

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

In Brief: Schmidt Asks NCI Grantees, Contractors To tell Him How They Waste Cancer Money

December 13, 1974

Advanced Screening Provides More Accurate Diagnosis

February 23, 2007

NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization

June 22, 1990

Cooperative Group Competing Renewals May Be Funded Only at 70-80% Of Amounts Recommended By CCIRC

January 2, 1981